Cloudflare emerged as the session's primary winner, with shares climbing 14% to $205.99 after the company reported a narrowed fourth-quarter loss. Management attributed the momentum to the rapid adoption of AI-driven services, positioning the network security firm as a key beneficiary of the ongoing enterprise shift toward generative artificial intelligence.
The broader market sentiment was dampened by a series of misses elsewhere. Lyft shares tumbled 15% to $14.24 after the ride-hailing platform’s active rider count and total trip volume failed to meet analyst projections. This growth slowdown suggests intensifying competition or cooling consumer demand in the gig economy sector.
Regulatory and Operational Hurdles
Moderna faced its own challenges as the FDA refused to review the company's new influenza vaccine application. The news triggered a 6.4% decline in share price to $39.32, marking a significant hurdle for the biotech firm’s strategy to expand its mRNA pipeline beyond pandemic-related products.
The most severe reaction was reserved for Angi, which plummeted 23% to $9.19. The company missed fourth-quarter estimates on both the top and bottom lines and issued a grim forecast for the coming months. According to the company's guidance, sales are expected to continue their decline through the first quarter, highlighting persistent friction in the home-services marketplace.
Comments (0)
No comments yet. Be the first!